10x Genomics is a biotechnology company based in Stockholm that specializes in decoding biological processes to enhance health outcomes. The company develops innovative products aimed at facilitating significant breakthroughs in scientific research and drug development. Their tools are particularly designed to address challenges in cancer treatment, supporting the creation of advanced therapies that can lead to improved patient care.
The company emphasizes the use of strong artificial intelligence models, which are built on extensive and robust data sets. This approach not only empowers researchers but also contributes to impactful scientific discoveries. With over 10,000 publications that have utilized their products, 10x Genomics has established a significant presence in the scientific community, demonstrating a commitment to advancing both scientific understanding and health outcomes.